▶ 調査レポート

注射型ドラッグデリバリーの世界市場

• 英文タイトル:Global Market Study on Injectable Drug Delivery: Rising Demand for Connected Injectable Drug Delivery Devices being Witnessed

Persistence Market Researchが調査・発行した産業分析レポートです。注射型ドラッグデリバリーの世界市場 / Global Market Study on Injectable Drug Delivery: Rising Demand for Connected Injectable Drug Delivery Devices being Witnessed / PMR20MY099資料のイメージです。• レポートコード:PMR20MY099
• 出版社/出版日:Persistence Market Research / 2020年3月9日
• レポート形態:英文、PDF、307ページ
• 納品方法:Eメール
• 産業分類:生命科学&トランスフォーメーショナルヘルス
• 販売価格(消費税別)
  Individual User(1名用)¥514,500 (USD4,900)▷ お問い合わせ
  Multi User(5名用)¥798,000 (USD7,600)▷ お問い合わせ
  Corporate User(企業用)¥1,113,000 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、世界の注射型ドラッグデリバリー市場について調査・分析し、エグゼクティブサマリー、市場概要、市場動向、市場成功要因、市場需要分析及び予測、技術分析、市場背景、北米、中南米、ヨーロッパ市場分析などを含め、以下の構成でお届け致します。
・世界の注射型ドラッグデリバリー市場:エグゼクティブサマリー
・世界の注射型ドラッグデリバリー市場:概要
・世界の注射型ドラッグデリバリー市場:動向
・世界の注射型ドラッグデリバリー市場:成功要因
・世界の注射型ドラッグデリバリー市場:需要分析及び予測
・世界の注射型ドラッグデリバリー市場:技術分析
・世界の注射型ドラッグデリバリー市場:背景
・北米の注射型ドラッグデリバリー市場:分析及び予測
・中南米の注射型ドラッグデリバリー市場:分析及び予測
・ヨーロッパの注射型ドラッグデリバリー市場:分析及び予測

Injectable Drug Delivery Market: Scope of the Report

Persistence Market Research (PMR) recently published a market study on the global injectable drug delivery market. The study provides detailed assessment on key market dynamics, including the drivers, trends, opportunities, restraints, and detailed information about the injectable drug delivery market structure. The market study presents exclusive information about how the injectable drug delivery market will grow during the forecast period of 2019-2029.

Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market and compounded annual growth rate (CAGR) are explained in PMR’s study in a comprehensive manner. Other information includes pricing analysis, which helps in deep understanding of the pricing details by researchers, suppliers, manufactures, and distributors. Other information contains volume analysis, which includes year-wise growth of the injectable drug delivery market during the forecast period. This information can help readers understand the quantitative growth prospects of the injectable drug delivery market for the forecast period.

The study is relevant for service providers, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Business researcher, shareholders, and industry experts can leverage the information and data presented in PMR’s study.

The study also includes statistics as well as facts related to the macroeconomic factors that are impacting developments in the injectable drug delivery market. It also offers actionable insights based on future trends in the injectable drug delivery market. Furthermore, small businesses and new entrants in the injectable drug delivery market too can make use of the information presented in this study, based on which, they can make appropriate business decisions in order to gain momentum in the market.

Key Questions Answered in PMR’s Injectable Drug Delivery Market Report

Which regions will continue to remain the most profitable regional markets for injectable drug delivery market players?
Which factors will induce a change in the growth of the injectable drug delivery market during the assessment period?
What are the different opportunities available for emerging players in the injectable drug delivery market?
How are supply-side and demand-side drivers impacting the injectable drug delivery market?
How will changing trends impact the injectable drug delivery market?
How can market players capture the low-hanging opportunities in the injectable drug delivery market in developed regions?
Which companies are leading the injectable drug delivery market?
What are the winning strategies of stakeholders in the injectable drug delivery market to upscale their position in this landscape?
Injectable Drug Delivery Market: Research Methodology

In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the injectable drug delivery market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the injectable drug delivery market study include statistics from government healthcare organizations, medicinal journals, research journals, press releases, annual reports, white papers, directories, and databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary resources and secondary resources acts as a validation from companies in the injectable drug delivery market, and makes PMR’s projection on the growth prospects of the injectable drug delivery market more accurate and reliable.

レポート目次

1. Executive Summary

1.1. Global Market Outlook

1.2. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Key Market Trends

4. Key Success Factors

4.1. Global Pharmaceutical Outlook

4.2. PEST Analysis

4.3. Key Disease Epidemiology

4.4. Parenteral Drugs Pipeline Assessment

4.5. Regulatory Landscape

4.6. Supply Chain analysis

5. Global Injectable Drug Delivery Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

5.2.1. Y-o-Y Growth Trend Analysis

5.2.2. Absolute $ Opportunity Analysis

6. Key Technologies Assessment

6.1. Under Clinical Development Injectable Drug Delivery Technologies

6.2. Commercialized Injectable Drug Delivery Technologies

7. Market Background

7.1. Macro-Economic Factors

7.2. Forecast Factors – Relevance & Impact

7.3. Market Dynamics

7.3.1. Drivers

7.3.2. Restraints

7.3.3. Opportunity Analysis

8. Global Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029, by Product Type

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2014 – 2018

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019 – 2029

8.3.1. Self-Injectors

8.3.1.1. Single Chamber Self Injectors

8.3.1.2. Dual Chamber Self Injectors

8.3.2. Needle Free Injectors

8.3.2.1. Pre Filled Needle Free Injectors

8.3.2.2. Fill-Able Needle free Injectors

8.3.3. Auto Injectors

8.3.3.1. Prefilled Auto Injectors

8.3.3.2. Fill-Able Auto Injectors

8.3.4. Wearable Injectors

8.3.4.1. Wearable Patch Injectors

8.3.4.2. Off-body Worn Injectors

8.3.5. Insulin Pens

8.3.5.1. Reusable Insulin Pens

8.3.5.2. Disposable Insulin Pens

8.3.5.3. Smart Insulin Pen Caps

8.4. Market Attractiveness Analysis By Product Type

9. Global Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029, by Technology

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Mn) Analysis By Technology, 2014 – 2018

9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2019 – 2029

9.3.1. Non-Smart Injectors

9.3.2. Smart Injectors

9.3.3. Artificial Intelligence (AI) and Machine Learning Integrated

9.3.4. Near Field Communication (NFC)

9.3.5. Cloud Computing

9.3.6. Bluetooth

9.4. Market Attractiveness Analysis By Technology

10. Global Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029, by Indication

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Mn) Analysis By Indication, 2014 – 2018

10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2019 – 2029

10.3.1. Anaphylaxis/ Asthma

10.3.2. Diabetes

10.3.3. Cardiovascular Diseases

10.3.4. Multiple Sclerosis

10.3.5. Rheumatoid Arthritis

10.3.6. Cancer

10.3.7. Trauma and Emergency

10.3.8. Others

10.4. Market Attractiveness Analysis By Indication

11. Global Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029, by Usage

11.1. Introduction / Key Findings

11.2. Historical Market Size (US$ Mn) Analysis By Usage, 2014 – 2018

11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Usage, 2019 – 2029

11.3.1. Disposable Injectors

11.3.2. Reusable Injectors

11.4. Market Attractiveness Analysis By Usage

12. Global Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel

12.1. Introduction / Key Findings

12.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014 – 2018

12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 – 2029

12.3.1. Hospital Pharmacies

12.3.2. Drug Stores

12.3.3. Retail Pharmacies

12.3.4. Online Pharmacies

12.4. Market Attractiveness Analysis By Distribution Channel

13. Global Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029, by Region

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 – 2018

13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 – 2029

13.3.1. North America

13.3.2. Latin America

13.3.3. Europe

13.3.4. South Asia

13.3.5. East Asia

13.3.6. Oceania

13.3.7. Middle East and Africa (MEA)

13.4. Market Attractiveness Analysis By Region

14. North America Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

14.1. Introduction

14.2. Pricing Analysis

14.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018

14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2019 – 2029

14.4.1. By Country

14.4.1.1. U.S.

14.4.1.2. Canada

14.4.2. By Product Type

14.4.3. By Technology

14.4.4. By Indication

14.4.5. By Usage

14.4.6. By Distribution Channel

14.5. Market Attractiveness Analysis

14.5.1. By Country

14.5.2. By Product Type

14.5.3. By Technology

14.5.4. By Indication

14.5.5. By Usage

14.5.6. By Distribution Channel

15. Latin America Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

15.1. Introduction

15.2. Pricing Analysis

15.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018

15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2019 – 2029

15.4.1. By Country

15.4.1.1. Brazil

15.4.1.2. Argentina

15.4.1.3. Mexico

15.4.1.4. Rest of Latin America

15.4.2. By Product Type

15.4.3. By Technology

15.4.4. By Indication

15.4.5. By Usage

15.4.6. By Distribution Channel

15.5. Market Attractiveness Analysis

15.5.1. By Country

15.5.2. By Product Type

15.5.3. By Technology

15.5.4. By Indication

15.5.5. By Usage

15.5.6. By Distribution Channel

16. Europe Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

16.1. Introduction

16.2. Pricing Analysis

16.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018

16.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

16.4.1. By Country

16.4.1.1. Germany

16.4.1.2. U.K.

16.4.1.3. France

16.4.1.4. France

16.4.1.5. Italy

16.4.1.6. Spain

16.4.1.7. Russia

16.4.1.8. Rest of Europe

16.4.2. By Product Type

16.4.3. By Technology

16.4.4. By Indication

16.4.5. By Usage

16.4.6. By Distribution Channel

16.5. Market Attractiveness Analysis

16.5.1. By Country

16.5.2. By Product Type

16.5.3. By Technology

16.5.4. By Indication

16.5.5. By Usage

16.5.6. By Distribution Channel

17. South Asia Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

17.1. Introduction

17.2. Pricing Analysis

17.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018

17.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

17.4.1. By Country

17.4.1.1. India

17.4.1.2. Thailand

17.4.1.3. Indonesia

17.4.1.4. Malaysia

17.4.1.5. Rest of South Asia

17.4.2. By Product Type

17.4.3. By Technology

17.4.4. By Indication

17.4.5. By Usage

17.4.6. By Distribution Channel

17.5. Market Attractiveness Analysis

17.5.1. By Country

17.5.2. By Product Type

17.5.3. By Technology

17.5.4. By Indication

17.5.5. By Usage

17.5.6. By Distribution Channel

18. East Asia Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

18.1. Introduction

18.2. Pricing Analysis

18.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018

18.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

18.4.1. By Country

18.4.1.1. China

18.4.1.2. Japan

18.4.1.3. South Korea

18.4.2. By Product Type

18.4.3. By Technology

18.4.4. By Indication

18.4.5. By Usage

18.4.6. By Distribution Channel

18.5. Market Attractiveness Analysis

18.5.1. By Country

18.5.2. By Product Type

18.5.3. By Technology

18.5.4. By Indication

18.5.5. By Usage

18.5.6. By Distribution Channel

19. Oceania Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

19.1. Introduction

19.2. Pricing Analysis

19.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018

19.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

19.4.1. By Country

19.4.1.1. Australia

19.4.1.2. New Zealand

19.4.2. By Product Type

19.4.3. By Technology

19.4.4. By Indication

19.4.5. By Usage

19.4.6. By Distribution Channel

19.5. Market Attractiveness Analysis

19.5.1. By Country

19.5.2. By Product Type

19.5.3. By Technology

19.5.4. By Indication

19.5.5. By Usage

19.5.6. By Distribution Channel

20. Middle East and Africa Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

20.1. Introduction

20.2. Pricing Analysis

20.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018

20.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

20.4.1. By Country

20.4.1.1. GCC Countries

20.4.1.2. Turkey

20.4.1.3. Northern Africa

20.4.1.4. South Africa

20.4.1.5. Rest of Middle East and Africa

20.4.2. By Product Type

20.4.3. By Technology

20.4.4. By Indication

20.4.5. By Usage

20.4.6. By Distribution Channel

20.5. Market Attractiveness Analysis

20.5.1. By Country

20.5.2. By Product Type

20.5.3. By Technology

20.5.4. By Indication

20.5.5. By Usage

20.5.6. By Distribution Channel

21. Key & Emerging Countries Analysis

21.1. U.S. Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

21.1.1. Introduction

21.1.2. Historical Market Size (US$ Mn) & Volume Units Trend Analysis By Market Taxonomy, 2014 – 2018

21.1.3. Market Size (US$ Mn) & Volume Units Forecast By Market Taxonomy, 2019 – 2029

21.1.3.1. By Product Type

21.1.3.2. By Technology

21.1.3.3. By Indication

21.1.3.4. By Usage

21.1.3.5. By Distribution Channel

21.1.4. Market Attractiveness Analysis

21.2. Canada Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

21.3. Brazil Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

21.4. Argentina Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

21.5. Mexico Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

21.6. Germany Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

21.7. U. K. Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

21.8. France Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

21.9. Italy Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

21.10. Spain Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

21.11. BENELUX Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

21.12. Russia Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

21.13. China Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

21.14. Japan Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

21.15. South Korea Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

21.16. Australia Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

21.17. New Zealand Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

21.18. South Africa Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

21.19. GCC Countries Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

21.20. Turkey Countries Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029

22. Market Structure Analysis

22.1. Market Analysis by Tier of Companies (Injectable Drug Delivery)

22.2. Market Share Analysis of Top Players

23. Competition Analysis

23.1. Competition Dashboard

23.2. Competition Deep Dive

23.2.1. Eli Lilly and Company

23.2.1.1. Overview

23.2.1.2. Product Portfolio

23.2.1.3. Profitability by Market Segments (Product/Channel/Region)

23.2.1.4. Sales Footprint

23.2.1.5. Strategy Overview

23.2.1.5.1. Marketing Strategy

23.2.1.5.2. Product Strategy

23.2.1.5.3. Channel Strategy

23.2.2. Biocon

23.2.2.1. Overview

23.2.2.2. Product Portfolio

23.2.2.3. Profitability by Market Segments (Product/Channel/Region)

23.2.2.4. Sales Footprint

23.2.2.5. Strategy Overview

23.2.2.5.1. Marketing Strategy

23.2.2.5.2. Product Strategy

23.2.2.5.3. Channel Strategy

23.2.3. Becton, Dickinson & Company

23.2.3.1. Overview

23.2.3.2. Product Portfolio

23.2.3.3. Profitability by Market Segments (Product/Channel/Region)

23.2.3.4. Sales Footprint

23.2.3.5. Strategy Overview

23.2.3.5.1. Marketing Strategy

23.2.3.5.2. Product Strategy

23.2.3.5.3. Channel Strategy

23.2.4. West Pharmaceutical Services, Inc.

23.2.4.1. Overview

23.2.4.2. Product Portfolio

23.2.4.3. Profitability by Market Segments (Product/Channel/Region)

23.2.4.4. Sales Footprint

23.2.4.5. Strategy Overview

23.2.4.5.1. Marketing Strategy

23.2.4.5.2. Product Strategy

23.2.4.5.3. Channel Strategy

23.2.5. Johnson & Johnson

23.2.5.1. Overview

23.2.5.2. Product Portfolio

23.2.5.3. Profitability by Market Segments (Product/Channel/Region)

23.2.5.4. Sales Footprint

23.2.5.5. Strategy Overview

23.2.5.5.1. Marketing Strategy

23.2.5.5.2. Product Strategy

23.2.5.5.3. Channel Strategy

23.2.6. Antares Pharma

23.2.6.1. Overview

23.2.6.2. Product Portfolio

23.2.6.3. Profitability by Market Segments (Product/Channel/Region)

23.2.6.4. Sales Footprint

23.2.6.5. Strategy Overview

23.2.6.5.1. Marketing Strategy

23.2.6.5.2. Product Strategy

23.2.6.5.3. Channel Strategy

23.2.7. AbbVie Inc.

23.2.7.1. Overview

23.2.7.2. Product Portfolio

23.2.7.3. Profitability by Market Segments (Product/Channel/Region)

23.2.7.4. Sales Footprint

23.2.7.5. Strategy Overview

23.2.7.5.1. Marketing Strategy

23.2.7.5.2. Product Strategy

23.2.7.5.3. Channel Strategy

23.2.8. Pfizer Inc.

23.2.8.1. Overview

23.2.8.2. Product Portfolio

23.2.8.3. Profitability by Market Segments (Product/Channel/Region)

23.2.8.4. Sales Footprint

23.2.8.5. Strategy Overview

23.2.8.5.1. Marketing Strategy

23.2.8.5.2. Product Strategy

23.2.8.5.3. Channel Strategy

23.2.9. Mylan N.V.

23.2.9.1. Overview

23.2.9.2. Product Portfolio

23.2.9.3. Profitability by Market Segments (Product/Channel/Region)

23.2.9.4. Sales Footprint

23.2.9.5. Strategy Overview

23.2.9.5.1. Marketing Strategy

23.2.9.5.2. Product Strategy

23.2.9.5.3. Channel Strategy

23.2.10. Vetter Pharma-Fertigung GmbH & Co.KG

23.2.10.1. Overview

23.2.10.2. Product Portfolio

23.2.10.3. Profitability by Market Segments (Product/Channel/Region)

23.2.10.4. Sales Footprint

23.2.10.5. Strategy Overview

23.2.10.5.1. Marketing Strategy

23.2.10.5.2. Product Strategy

23.2.10.5.3. Channel Strategy

23.2.11. Emperra GmbH

23.2.11.1. Overview

23.2.11.2. Product Portfolio

23.2.11.3. Profitability by Market Segments (Product/Channel/Region)

23.2.11.4. Sales Footprint

23.2.11.5. Strategy Overview

23.2.11.5.1. Marketing Strategy

23.2.11.5.2. Product Strategy

23.2.11.5.3. Channel Strategy

23.2.12. Digital Medics Pty Ltd

23.2.12.1. Overview

23.2.12.2. Product Portfolio

23.2.12.3. Profitability by Market Segments (Product/Channel/Region)

23.2.12.4. Sales Footprint

23.2.12.5. Strategy Overview

23.2.12.5.1. Marketing Strategy

23.2.12.5.2. Product Strategy

23.2.12.5.3. Channel Strategy

23.2.13. Enable Injections LLC

23.2.13.1. Overview

23.2.13.2. Product Portfolio

23.2.13.3. Profitability by Market Segments (Product/Channel/Region)

23.2.13.4. Sales Footprint

23.2.13.5. Strategy Overview

23.2.13.5.1. Marketing Strategy

23.2.13.5.2. Product Strategy

23.2.13.5.3. Channel Strategy

23.2.14. Insulet corporation

23.2.14.1. Overview

23.2.14.2. Product Portfolio

23.2.14.3. Profitability by Market Segments (Product/Channel/Region)

23.2.14.4. Sales Footprint

23.2.14.5. Strategy Overview

23.2.14.5.1. Marketing Strategy

23.2.14.5.2. Product Strategy

23.2.14.5.3. Channel Strategy

23.2.15. Consort Medical Plc

23.2.15.1. Overview

23.2.15.2. Product Portfolio

23.2.15.3. Profitability by Market Segments (Product/Channel/Region)

23.2.15.4. Sales Footprint

23.2.15.5. Strategy Overview

23.2.15.5.1. Marketing Strategy

23.2.15.5.2. Product Strategy

23.2.15.5.3. Channel Strategy

23.2.16. Diabnext

23.2.16.1. Overview

23.2.16.2. Product Portfolio

23.2.16.3. Profitability by Market Segments (Product/Channel/Region)

23.2.16.4. Sales Footprint

23.2.16.5. Strategy Overview

23.2.16.5.1. Marketing Strategy

23.2.16.5.2. Product Strategy

23.2.16.5.3. Channel Strategy

23.2.17. Diamesco Co., Ltd

23.2.17.1. Overview

23.2.17.2. Product Portfolio

23.2.17.3. Profitability by Market Segments (Product/Channel/Region)

23.2.17.4. Sales Footprint

23.2.17.5. Strategy Overview

23.2.17.5.1. Marketing Strategy

23.2.17.5.2. Product Strategy

23.2.17.5.3. Channel Strategy

23.2.18. SCHOTT AG

23.2.18.1. Overview

23.2.18.2. Product Portfolio

23.2.18.3. Profitability by Market Segments (Product/Channel/Region)

23.2.18.4. Sales Footprint

23.2.18.5. Strategy Overview

23.2.18.5.1. Marketing Strategy

23.2.18.5.2. Product Strategy

23.2.18.5.3. Channel Strategy

23.2.19. SiO2 Medical Products

23.2.19.1. Overview

23.2.19.2. Product Portfolio

23.2.19.3. Profitability by Market Segments (Product/Channel/Region)

23.2.19.4. Sales Footprint

23.2.19.5. Strategy Overview

23.2.19.5.1. Marketing Strategy

23.2.19.5.2. Product Strategy

23.2.19.5.3. Channel Strategy

23.2.20. Integrity Bio, Inc.

23.2.20.1. Overview

23.2.20.2. Product Portfolio

23.2.20.3. Profitability by Market Segments (Product/Channel/Region)

23.2.20.4. Sales Footprint

23.2.20.5. Strategy Overview

23.2.20.5.1. Marketing Strategy

23.2.20.5.2. Product Strategy

23.2.20.5.3. Channel Strategy

23.2.21. Wilhelm Haselmeier GmbH & Co. KG

23.2.21.1. Overview

23.2.21.2. Product Portfolio

23.2.21.3. Profitability by Market Segments (Product/Channel/Region)

23.2.21.4. Sales Footprint

23.2.21.5. Strategy Overview

23.2.21.5.1. Marketing Strategy

23.2.21.5.2. Product Strategy

23.2.21.5.3. Channel Strategy

23.2.22. Tandem Diabetes Care

23.2.22.1. Overview

23.2.22.2. Product Portfolio

23.2.22.3. Profitability by Market Segments (Product/Channel/Region)

23.2.22.4. Sales Footprint

23.2.22.5. Strategy Overview

23.2.22.5.1. Marketing Strategy

23.2.22.5.2. Product Strategy

23.2.22.5.3. Channel Strategy

23.2.23. Sanofi S.A.

23.2.23.1. Overview

23.2.23.2. Product Portfolio

23.2.23.3. Profitability by Market Segments (Product/Channel/Region)

23.2.23.4. Sales Footprint

23.2.23.5. Strategy Overview

23.2.23.5.1. Marketing Strategy

23.2.23.5.2. Product Strategy

23.2.23.5.3. Channel Strategy

23.2.24. Companion Medical Inc.

23.2.24.1. Overview

23.2.24.2. Product Portfolio

23.2.24.3. Profitability by Market Segments (Product/Channel/Region)

23.2.24.4. Sales Footprint

23.2.24.5. Strategy Overview

23.2.24.5.1. Marketing Strategy

23.2.24.5.2. Product Strategy

23.2.24.5.3. Channel Strategy

23.2.25. Ypsomed

23.2.25.1. Overview

23.2.25.2. Product Portfolio

23.2.25.3. Profitability by Market Segments (Product/Channel/Region)

23.2.25.4. Sales Footprint

23.2.25.5. Strategy Overview

23.2.25.5.1. Marketing Strategy

23.2.25.5.2. Product Strategy

23.2.25.5.3. Channel Strategy

23.2.26. Hoffman – La Roche Ltd.

23.2.26.1. Overview

23.2.26.2. Product Portfolio

23.2.26.3. Profitability by Market Segments (Product/Channel/Region)

23.2.26.4. Sales Footprint

23.2.26.5. Strategy Overview

23.2.26.5.1. Marketing Strategy

23.2.26.5.2. Product Strategy

23.2.26.5.3. Channel Strategy

23.2.27. Novo Nordisk A/S

23.2.27.1. Overview

23.2.27.2. Product Portfolio

23.2.27.3. Profitability by Market Segments (Product/Channel/Region)

23.2.27.4. Sales Footprint

23.2.27.5. Strategy Overview

23.2.27.5.1. Marketing Strategy

23.2.27.5.2. Product Strategy

23.2.27.5.3. Channel Strategy

23.2.28. Medtronic Plc.

23.2.28.1. Overview

23.2.28.2. Product Portfolio

23.2.28.3. Profitability by Market Segments (Product/Channel/Region)

23.2.28.4. Sales Footprint

23.2.28.5. Strategy Overview

23.2.28.5.1. Marketing Strategy

23.2.28.5.2. Product Strategy

23.2.28.5.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

List of Tables

Table 02: Global Injectable Drug Delivery Market Value (US$ Bn) Analysis 2014–2018 and Forecast 2019–2029, by Technology

Table 03: Global Injectable Drug Delivery Market Value (US$ Bn) Analysis 2014–2018 and Forecast 2019–2029, by Usage

Table 04: Global Injectable Drug Delivery Market Value (US$ Bn) Analysis 2014–2018 and Forecast 2019–2029, by Indication

Table 05: Global Injectable Drug Delivery Market Value (US$ Bn) Analysis 2014–2018 and Forecast 2019–2029, by Distribution Channel

Table 06: Global Injectable Drug Delivery Market Value (US$ Bn) Analysis 2014–2018 and Forecast 2019–2029, by Region

Table 07: North America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Country

Table 08: North America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Product Type

Table 09: North America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Technology

Table 10: North America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Usage

Table 11: North America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Indication

Table 12: North America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Distribution Channel

Table 13: Latin America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Country

Table 14: Latin America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Product Type

Table 15: Latin America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Technology

Table 16: Latin America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Usage

Table 17: Latin America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Indication

Table 18: Latin America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–018 and Forecast 2019–2029, by Distribution Channel

Table 19: Europe Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Country

Table 20: Europe Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Product Type

Table 21: Europe Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Technology

able 22: Europe Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Usage

Table 23: Europe Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Indication

Table 24: Europe Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Distribution Channel

Table 25: South Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Country

Table 26: South Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Product Type

Table 27: South Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Technology

Table 28: South Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Usage

Table 29: South Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Indication

able 30: South Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Distribution Channel

Table 31: East Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Country

Table 32: East Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Product Type

Table 33: East Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Technology

Table 34: East Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Usage

Table 35: East Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Indication

Table 36: East Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Distribution Channel

Table 37: Oceania Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Country

Table 38: Oceania Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Product Type

Table 39: Oceania Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Technology

Table 40: Oceania Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Usage

Table 41: Oceania Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Indication

Table 42: Oceania Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Distribution Channel

Table 43: MEA Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Country

Table 44: MEA Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Product Type

Table 45: MEA Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Technology

Table 46: MEA Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Usage

Table 47: MEA Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Indication

Table 48: MEA Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Distribution Channel